| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |